This website is no longer being updated. Please visit GBCHealth’s new website at: www.gbchealth.org.

Global Fund Private Sector Delegation

Over the past decade, the Global Fund to Fight AIDS, Tuberculosis and Malaria has helped save millions of lives around the world. The private sector has played a vital role in this private-public partnership.

The Private Sector Delegation (PSD) is a group of companies that brings the business voice to the Global Fund and helps shape the strategy of the leading funding agency in global health. GBCHealth serves the role of Focal Point, providing an entry-point for private sector collaboration with the Global Fund and overseeing, managing and coordinating the PSD.  In this role, GBCHealth works with dozens of committed businesses who bring their expertise, assets and networks to the Global Fund.

The Global Fund represents one of the most efficient avenues for business investment in these pandemics, while also providing opportunities for co-financing and collaboration on the ground. To date, the Global Fund has committed $22.6 billion in funding to more than 1,000 programs in 150 countries – an unprecedented investment. Read more on The Global Fund in Action.

>> Read more about The Global Fund and the Private Sector

>> Read the Private Sector Delegation's 2012 Annual Report here

Advisory Group: Bringing the Private Sector’s Voice to the Global Fund

Within the Private Sector Delegation is a core group of engaged companies – currently 17 – called the PSD Advisory Group. The Advisory Group provides technical know-how, helps shape policies and priorities and represents the private sector during each Board meeting.  The Advisory Group also elects the private sector’s voting Board Member and Alternate Board Member to the Global Fund. Paul Schaper of Merck and Renuka Gadde of BD lead the Advisory Group and serve, respectively, as the private sector’s voting Board and Alternate Board member. This team of private sector representatives ensures that Global Fund initiatives actively engage the business sector, while bringing assets and core expertise to help improve the Global Fund’s efficiency. Read more about the new Board Member and Alternate Board Member here.

The Advisory Group participates in high-level meetings and events with government, NGOs and Global Fund representatives, engages the Global Fund on policy issues and serves on Board committees and taskforces.  Each Advisory Group member is required to sign a Conflict of Interest form to ensure that the group is acting in the interest of the Global Fund and private sector constituency.

GBCHealth and the Global Fund

As the Focal Point for the Private Sector Delegation to the Global Fund, GBCHealth works with businesses willing to contribute their expertise, advise the Board's deliberations, ensure that the Global Fund remains performance-driven and advocate for the business role in global health. The PSD Focal Point, GBCHealth’s Whitney White, coordinates activities and works hand-in-hand with the Advisory Group and the broader group of active companies to drive private sector engagement with the Global Fund.

>> View the PSD Overview in PDF

>> View the list of Advisory Group and Constituency Members

See video on the Global Fund from GBCHealth's 2012 Conference.

Private Sector Global Fund Contributions

Since the Global Fund’s establishment in 2002, businesses have contributed their assets and expertise to the Global Fund. Their contributions range from financial contributions, technical services and advocacy to co-investments and operational support of in-country programs.  Examples include: 

  • CORPORATE CHAMPION – Chevron became the first Global Fund Corporate Champion in January 2008 when they announced a US$ 30 million commitment to the Global Fund at the World Economic Forum. Since then, they have increased their six-year investment (2008-2013) to a total of $US 55 million. This is now the largest contribution from a single corporation to the Global Fund.

For more information on Chevron’s role as Corporate Champion, please click here.

  • MULTI-YEAR CONTRIBUTIONS – BHP Billiton Sustainable Communities’ has contributed US $10 million to the Global Fund to achieve universal malaria prevention coverage in Mozambique by 2014. The contribution will be made over 2014-2016, and additional interventions will be made every year to support the goal of universal coverage.

For more information on BHP Billiton’s contribution and partnership with the Global Fund, please click here.

  • MULTI-YEAR CONTRIBUTIONS – Takeda Pharmaceutical Company contributed US $10 million to the Global Fund, over the 2010-2019, period to strengthen the capacity of healthcare workers in Africa. Part of the “Takeda Initiative” these funds will be directed to Global Fund programs for health systems strengthening and human capacity development initiatives.

For more information about Takeda's partnership with the Global Fund, please click here.

  • MULTI-YEAR CONTRIBUTIONS – Vale, the Brazilian-based metals and mining company, contributed $3 million over 2013-2015 to the Global Fund, marking the first time a Latin American company has made a direct contribution to the Fund. Vale’s donation will help support malaria programs in Mozambique and Malawi.

For more information on Vale's contribution to the Global Fund, please click here.

  • INNOVATION COALITION – Eli Lilly & Company joined the International Federation of Pharmaceutical Manufactures and Associations (IFPMA) and the Global Fund in an innovative partnership to combat fake medicines. The program is part of a new Global Fund platform to leverage companies' skills and technical know-how to improve the impact of grant programs. Fake medicines represent 10% of the world’s pharmaceutical supply, and up to 30% in some regions.

For more information on the Fight the Fakes program, please click here.

  • INNOVATION COALITION – SAP partnered with USAID and Grant Management Solutions to develop a grant oversight platform to enable Principle Recipients to make better and more informed decisions on grant management and performance. The partnership will provide a grant management dashboard to 6 pilot countries beginning in February 2014.

For more information about the Grant Management Solutions partnership, please click here.

  • CO-INVESTMENT – SABMillerSABCOHA and the South African government are partnering with the Global Fund on five HIV/AIDS initiatives. The Fund’s contribution of R36million is being further strengthened through SABMiller’s additional resources.

For more information on SABMiller’s partnership with the Global Fund, please click here.

  • CO-INVESTMENT – Marathon Oil is helping to lead the “Bioko Island Malaria Project” with the Government of Equatorial Guinea, Noble Energy, GEPetrol and SONAGAS. In 2008, these partners announced a five-year $28 million extension of the project with a $26 million contribution from the Global Fund.

For more information on the extension of the Bioko Island Malaria Project, please click here.

  • INNOVATIVE FINANCING – Product (RED) was created by Bono to generate sustainable funds for life-saving HIV/AIDS treatment in Africa. The campaign has attracted a range of companies from Starbucks to Dell to create (RED) products with proceeds benefiting the Global Fund. To date, (RED) products have raised more than $190 million for Global Fund programs, making Product (RED) the largest private sector financial contributor to the Global Fund.

For more information on Product (RED), please click here.

  • IN-KIND CONTRIBUTIONS – Novartis and Sanofi, leading manufacturers of artemisinin-based combination therapies (ACTs), the most effective malaria treatment, are providing their medicines at not-for-profit prices to increase access to those in most need. Their contributions are being channeled through the Affordable Medicines Facility – malaria (AMFm) initiative, which is managed by the Global Fund.

For more information on AMFm, please click here.

  •  ‘GIFT FROM AFRICA’  Access Bank is leading a collective funding initiative with other African based companies to benefit The Global Fund. The ‘Gift From Africa’ campaign “demonstrate[s] to the world that Africans are prepared to share the responsibility for solving Africa’s challenges” (Aigboje Aig-Imoukhuede, Group Managing Director, Access Bank and Chairman of Friends of the Global Fund Africa)

For more information on Access Bank and ‘Gift from Africa’, please click here.

  • CORPORATE PLEDGE at G20 BUSINESS SUMMIT – Anglo American plc with Takeda Pharmaceuticals led a Call for Joint Action on Global Health at the G20 Business Summit in Seoul, South Korea. At the Summit, Anglo American pledged a contribution of $US 3 million to the Global Fund over 3 years.

For more information on Anglo American’s Global Fund contribution, please click here.

  • PRO-BONO SERVICES – Standard Bank and the Global Fund entered into a pro-bono partnership in December 2008 in which the Bank provides financial and management training to grant recipients in select countries.  It is entirely demand-driven and free of any conditionality. The partnership is currently active in Uganda, Nigeria, Swaziland, Lesotho, Mozambique and Zimbabwe.

For more information on the Standard Bank partnership, please click here.

  • SUPPLY CHAIN MANAGEMENT – The Coca-Cola Company is working with the Tanzanian Ministry of Health’s Medical Stores Department (MSD) to assist with their supply chain management and ensure essential medicines are made available in a time/cost-effective manner. Tanzania has the second largest Global Fund grant in sub-Saharan Africa. Early outcomes from the pilot project have shown a 25% cost savings on the distribution network.

For more information on the Coca-Cola’s sustainability programs, please click here.

  • PRIMARY RECIPIENT OF GLOBAL FUND GRANT – AngloGold Ashanti became the first private sector Principal Recipient in Africa with a Global Fund grant of up to US $130 million. Through this additional funding they will expand their successful integrated malaria control program into 40 districts in Ghana, through a public-private partnership model.

For more information on AngloGold Ashanti's malaria control program, please click here.

Facilitating In-country Engagement

Many private sector companies, including GBCHealth members, are actively involved with the Global Fund's Country Coordinating Mechanisms (CCMs), the local bodies overseeing the Global Fund grant application and stewardship process in country. Initiatives that are approved by the CCMs and implemented on the ground are frequently in need of co-financing or management support from the private sector.

GBCHealth Member CCM Engagement

AngloGold Ashanti

Ghana

Bralima (subsidiary of HEINEKEN)

Democratic Republic of Congo

Brarudi (subsidiary of HEINEKEN)

Burundi

Chevron

Nigeria

De Beers

South Africa

HSBC

Mauritius

Pfizer Philippines Foundation

Philippines

Scotiabank

Guyana

Standard Chartered Bank

Malaysia

    *List current as of February 2013

GBCHealth identifies opportunities to connect member companies to such strategic opportunities on the ground, identifying gaps where business competencies or resources can make real impact. The PSD Focal Point also works with National Business Coalitions (NBCs) to ensure their in-country knowledge and expertise is reflected at the Board level.

Learn how your company can contribute to the Global Fund

>>Read GBCHealth’s Private Sector Guide to the Global Fund

Additional Resources

>> Read the latest Global Fund PSD Newsletter

>>Learn more about The Global Fund

>>Review the Global Fund 2012 Results Report

>>Sign up for the Global Fund Observer free e-newsletter about the Global Fund

>>Listen to African Health Ministers talk about the Global Fund in Rwanda, Botswana and Lesotho

>>Global Fund Grant Review Body Seeks New Members - Apply Today

For more information about the Global Fund Private Sector Delegation or to receive upcoming PSD Newsletters, please contact Whitney White, Focal Point, at psd@gbchealth.org.

© 2012 GBCHealth